Anticipatory antifungal treatment in critically ill patients with sars-cov-2 pneumonia

HIGHLIGHTS

• who: u00c1ngel Estella et al. from the Intensive Care Unit, Medicine Department, University of Cu00e1diz, University Hospital of Jerez, INIBiCA, Jerez, Spain have published the paper: Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate the incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in critically ill patients and the impact of anticipatory antifungal treatment on the incidence of CAPA in critically ill patients. The authors report some novel aspects that are worth mentioning.
• how: The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.